Roundup: Mississippi River bridge / Vaccine lotteries / COVID pill 

Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.

Location, location: The Baton Rouge Area Chamber will be discussing potential sites for a new Mississippi River Bridge at its November monthly lunch at 11:30 a.m., Nov. 2. Atlas Technical Consultants has been contracted by the Department of Transportation and Development to narrow down sites suitable for a new bridge, and Atlas environmental manager Kara Moree will detail the process at the luncheon. Get more information here.  

Did they work? A new study published in the Jama Health Forum found that vaccine lotteries, like Lousiaian’s “Shot at 100” campaign, did not help get more people vaccinated, WAFB-TV reports. The study looked at vaccination rates in 19 states that entered people into a cash drawing after they got a vaccine this summer, and found no real significant difference between states that had the vaccine lottos and those that didn’t. Read more. 

Greater access:  Pharmaceutical company Merck today announced it has agreed to allow other drugmakers to produce its COVID-19 pill, which is an antiviral medication that people can take at home to reduce coronavirus symptoms and speed up recovery. The move will help millions of people get access to the drug and potentially reduce hospitalizations from the virus. Read the full story.

Advertisement

 

Discussion (0)

From Our Partners

Daily Report Poll

ASK AI

Ask anything about Baton Rouge business